Endothelin Receptors and Pain

Journal of Pain

Volumn 10, Issue 1, 2009, Pages 4-28

  Khodorova, Alla ^a   Montmayeur, Jean Pierre ^a   Strichartz, Gary ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

endothelin receptors; endothelin 1; Endothelins; hyperalgesia; pain

Indexed keywords

ACETYLSALICYLIC ACID; ATRASENTAN; BOSENTAN; CARRAGEENAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIZOCILPINE; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; IBUPROFEN; INDOMETACIN; ION CHANNEL; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; NAPROXEN; PROSTAGLANDIN E2; SARAFOTOXIN S6C; TOLMETIN;

ANTINOCICEPTION; CANCER PAIN; CLINICAL TRIAL; DESENSITIZATION; HUMAN; HYPERALGESIA; IN VITRO STUDY; INFLAMMATION; INJURY; INTERNALIZATION; NEUROPATHIC PAIN; NEUROTRANSMITTER RELEASE; NOCICEPTION; NONHUMAN; PAIN; PERIPHERAL VASCULAR SYSTEM; PROTEIN STRUCTURE; RAYNAUD PHENOMENON; REVIEW; SICKLE CELL ANEMIA; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

ANIMALS; ENDOTHELINS; HUMANS; HYPERALGESIA; MODELS, BIOLOGICAL; PAIN; RECEPTORS, ENDOTHELIN; SIGNAL TRANSDUCTION;

EID: 57849165414     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2008.09.009     Document Type: Review

References (276)

1. Ahn G.Y., Butt K.I., Jindo T., Yaguchi H., Tsuboi R., and Ogawa H. The expression of endothelin-1 and its binding sites in mouse skin increased after ultraviolet B irradiation or local injection of tumor necrosis factor alpha. J Dermatol 25 (1998) 78-84
2. Aley K.O., McCarter G., and Levine J.D. Nitric oxide signaling in pain and nociceptor sensitization in the rat. J Neurosci 18 (1998) 7008-7014
3. Ambar I., and Sokolovsky M. Endothelin receptors stimulate both phospholipase C and phospholipase D activities in different cell lines. Eur J Pharmacol 245 (1993) 31-41
4. Angelova K., Puett D., and Narayan P. Identification of endothelin receptor subtypes in sheep choroid plexus. Endocrine 7 (1997) 287-293
5. Arai H., Hori S., Aramori I., Ohkubo H., and Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348 (1990) 730-732
6. Aramori I., and Nakanishi S. Coupling of two endothelin receptor subtypes to differing signal transduction in transfected Chinese hamster ovary cells. J Biol Chem 267 (1992) 12468-12474
7. Baamonde A., Lastra A., Villazon M., Bordallo J., Hidalgo A., and Menendez L. Involvement of endogenous endothelins in thermal and mechanical inflammatory hyperalgesia in mice. Naunyn Schmiedebergs Arch Pharmacol 369 (2004) 245-251
8. Bagnato A., Cirilli A., Salani D., Simeone P., Muller A., Nicotra M.R., Natali P.G., and Venuti A. Growth inhibition of cervix carcinoma cells in vivo by endothelin A receptor blockade. Cancer Res 62 (2002) 6381-6384
9. Bagnato A., Rosano L., Spinella F., Di Castro V., Tecce R., and Natali P.G. Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression. Cancer Res 64 (2004) 1436-1443
10. Bagnato A., and Rosano L. The endothelin axis in cancer. Int J Biochem Cell Biol 86 (2008) 473-484
11. Baker M.D., Chandra S.Y., Ding Y., Waxman S.G., and Wood J.N. GTP-induced tetrodotoxin-resistant Na+ current regulates excitability in mouse and rat small diameter sensory neurones. J Physiol 548 (2003) 373-382
12. Baker M.D. Protein kinase C mediates up-regulation of tetrodotoxin-resistant, persistent Na+ current in rat and mouse sensory neurones. J Physiol 567 (2005) 851-867
13. Ballas S.K., and Smith E.D. Red blood cell changes during the evolution of the sickle cell painful crisis. Blood 79 (1992) 2154-2163
14. Balonov K., Khodorova A., and Strichartz G.R. Tactile allodynia initiated by local subcutaneous endothelin-1 is prolonged by activation of TRPV-1 receptors. Exp Biol Med (Maywood) 231 (2006) 1165-1170
15. Baslund B., Tvede N., Danneskiold-Samsoe B., Larsson P., Panayi G., Petersen J., Petersen L.J., Beurskens F.J., Schuurman J., van de Winkel J.G., Parren P.W., Gracie J.A., Jongbloed S., Liew F.Y., and McInnes I.B. Targeting interleukin-15 in patients with rheumatoid arthritis: A proof-of-concept study. Arthritis Rheum 52 (2005) 2686-2692
16. Bernard G., and Shevell M.I. Channelopathies: A review. Pediatr Neurol 38 (2008) 73-85
17. Bertelli A., Clerico A., Chicca A., Giovannini L., Gorio A., and Romano M.A. Role of endothelin-1 in carrageenin-induced inflammation. Int J Tissue React 14 (1992) 225-230
18. Berti-Mattera L.N., Gariepy C.E., Burke R.M., and Hall A.K. Reduced expression of endothelin B receptors and mechanical hyperalgesia in experimental chronic diabetes. Exp Neurol 201 (2006) 399-406
19. Beyer J.E., Simmons L.E., Woods G.M., and Woods P.M. A chronology of pain and comfort in children with sickle cell disease. Arch Pediatr Adolesc Med 153 (1999) 913-920
20. Bhalla S., Matwyshyn G., and Gulati A. Potentiation of morphine analgesia by BQ123, an endothelin antagonist. Peptides 23 (2002) 1837-1845
21. Bhalla S., Matwyshyn G., and Gulati A. Endothelin receptor antagonists restore morphine analgesia in morphine tolerant rats. Peptides 24 (2003) 553-561
22. Bhalla S., Matwyshyn G., and Gulati A. Central endothelin-B receptor stimulation does not affect morphine analgesia in rats. Pharmacology 72 (2004) 20-25
23. Bhalla S., Ciaccio N., Wang Z.J., and Gulati A. Involvement of endothelin in morphine tolerance in neuroblastoma (SH-SY5Y) cells. Exp Biol Med (Maywood) 231 (2006) 1152-1156
24. Bloch K.D., Hong C.C., Eddy R.L., Shows T.B., and Quertermous T. cDNA cloning and chromosomal assignment of the endothelin 2 gene: Vasoactive intestinal contractor peptide is rat endothelin 2. Genomics 10 (1991) 236-242
25. Boivin S., Tessier S., Aubin J., Lampron P., Detheux M., and Fournier A. Identification of a binding domain of the endothelin-B receptor using a selective IRL-1620-derived photoprobe. Biochemistry 43 (2004) 11516-11525
26. Bourgeois C., Robert B., Rebourcet R., Mondon F., Mignot T.M., Duc-Goiran P., and Ferre F. Endothelin-1 and ETA receptor expression in vascular smooth muscle cells from human placenta: A new ETA receptor messenger ribonucleic acid is generated by alternative splicing of exon 3. J Clin Endocrinol Metab 82 (1997) 3116-3123
27. Bourson A., Moser P.C., Gower A.J., and Mir A.K. Central and peripheral effects of the dihydropyridine calcium channel activator BAY K 8644 in the rat. Eur J Pharmacol 160 (1989) 339-347
28. Brain S.D., Tippins J.R., and Williams T.J. Endothelin induces potent microvascular constriction. Br J Pharmacol 95 (1988) 1005-1007
29. Bremnes T., Paasche J.D., Mehlum A., Sandberg C., Bremnes B., and Attramadal H. Regulation and intracellular trafficking pathways of the endothelin receptors. J Biol Chem 275 (2000) 17596-17604
30. Brennan T.J. Frontiers in translational research: The etiology of incisional and postoperative pain. Anesthesiology 97 (2002) 535-537
31. Brombacher F., Kastelein R.A., and Alber G. Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol 24 (2003) 207-212
32. Burkhardt Soares S., Fehr A., Brandt A.S., and Roth S. [Retroperitoneal fibrosis]. Aktuelle Urol 38 (2007) 221-231
33. Cain D.M., Wacnik P.W., Eikmeier L., Beitz A., Wilcox G.L., and Simone D.A. Functional interactions between tumor and peripheral nerve in a model of cancer pain in the mouse. Pain Med 2 (2001) 15-23
34. Calcutt N.A., and Chaplan S.R. Spinal pharmacology of tactile allodynia in diabetic rats. Br J Pharmacol 122 (1997) 1478-1482
35. Cameron N.E., Cotter M.A., and Low P.A. Nerve blood flow in early experimental diabetes in rats: Relation to conduction deficits. Am J Physiol 261 (1991) E1-E8
36. Cameron N.E., and Cotter M.A. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes 46 Suppl 2 (1997) S31-S37
37. Campbell J.N., and Meyer R.A. Mechanisms of neuropathic pain. Neuron 52 (2006) 77-92
38. Canetti C., Silva J.S., Ferreira S.H., and Cunha F.Q. Tumour necrosis factor-alpha and leukotriene B(4) mediate the neutrophil migration in immune inflammation. Br J Pharmacol 134 (2001) 1619-1628
39. Cardenas L.M., Cardenas C.G., and Scroggs R.S. 5HT increases excitability of nociceptor-like rat dorsal root ganglion neurons via cAMP-coupled TTX-resistant Na(+) channels. J Neurophysiol 86 (2001) 241-248
40. Carducci M.A., and Jimeno A. Targeting bone metastasis in prostate cancer with endothelin receptor antagonists. Clin Cancer Res 12 (2006) 6296s-6300s
41. Carducci M.A., Saad F., Abrahamsson P.A., Dearnaley D.P., Schulman C.C., North S.A., Sleep D.J., Isaacson J.D., and Nelson J.B. A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer. Cancer 110 (2007) 1959-1966
42. Cheng X., Ji Z., Tsalkova T., and Mei F. Epac and PKA: A tale of two intracellular cAMP receptors. Acta Biochim Biophys Sin (Shanghai) 40 (2008) 651-662
43. Chichorro J.G., Zampronio A.R., and Rae G.A. Endothelin ET(B) receptor antagonist reduces mechanical allodynia in rats with trigeminal neuropathic pain. Exp Biol Med (Maywood) 231 (2006) 1136-1140
44. Chichorro J.G., Zampronio A.R., Souza G.E., and Rae G.A. Orofacial cold hyperalgesia due to infraorbital nerve constriction injury in rats: Reversal by endothelin receptor antagonists but not non-steroidal anti-inflammatory drugs. Pain 123 (2006) 64-74
45. Chung M.K., Lee H., Mizuno A., Suzuki M., and Caterina M.J. TRPV3 and TRPV4 mediate warmth-evoked currents in primary mouse keratinocytes. J Biol Chem 279 (2004) 21569-21575
46. Cooke J.P., and Marshall J.M. Mechanisms of Raynaud's disease. Vasc Med 10 (2005) 293-307
47. Crossman D.C., Brain S.D., and Fuller R.W. Potent vasoactive properties of endothelin 1 in human skin. J Appl Physiol 70 (1991) 260-266
48. D'Amico M., Berrino L., Maione S., Filippelli A., de Novellis V., and Rossi F. Endothelin-1 in periaqueductal gray area of mice induces analgesia via glutamatergic receptors. Pain 65 (1996) 205-209
49. da Cunha J.M., Rae G.A., Ferreira S.H., and Cunha Fde Q. Endothelins induce ETB receptor-mediated mechanical hypernociception in rat hind paw: Roles of cAMP and protein kinase C. Eur J Pharmacol 501 (2004) 87-94
50. Daher J.B., Souza G.E., D'Orleans-Juste P., and Rae G.A. Endothelin ETB receptors inhibit articular nociception and priming induced by carrageenan in the rat knee-joint. Eur J Pharmacol 496 (2004) 77-85
51. Dahlof B., Gustafsson D., Hedner T., Jern S., and Hansson L. Regional haemodynamic effects of endothelin-1 in rat and man: Unexpected adverse reaction. J Hypertens 8 (1990) 811-817
52. Davar G., Hans G., Fareed M.U., Sinnott C., and Strichartz G. Behavioral signs of acute pain produced by application of endothelin-1 to rat sciatic nerve. Neuroreport 9 (1998) 2279-2283
53. Davenport A.P., and Kuc R.E. Cellular expression of isoforms of endothelin-converting enzyme-1 (ECE-1c, ECE-1b and ECE-1a) and endothelin-converting enzyme-2. J Cardiovasc Pharmacol 36 (2000) S12-S14
54. Davenport A.P. International Union of Pharmacology, XXIX: Update on endothelin receptor nomenclature. Pharmacol Rev 54 (2002) 219-226
55. De-Melo J.D., Tonussi C.R., D'Orleans-Juste P., and Rae G.A. Effects of endothelin-1 on inflammatory incapacitation of the rat knee joint. J Cardiovasc Pharmacol 31 Suppl 1 (1998) S518-S520
56. De-Melo J.D., Tonussi C.R., D'Orleans-Juste P., and Rae G.A. Articular nociception induced by endothelin-1, carrageenan and LPS in naive and previously inflamed knee-joints in the rat: Inhibition by endothelin receptor antagonists. Pain 77 (1998) 261-269
57. Druml W., Steltzer H., Waldhausl W., Lenz K., Hammerle A., Vierhapper H., Gasic S., and Wagner O.F. Endothelin-1 in adult respiratory distress syndrome. Am Rev Respir Dis 148 (1993) 1169-1173
58. Duarte A.M., Pospisilova E., Reilly E., Mujenda F., Hamaya Y., and Strichartz G.R. Reduction of postincisional allodynia by subcutaneous bupivacaine: Findings with a new model in the hairy skin of the rat. Anesthesiology 103 (2005) 113-125
59. Dupuis J., Goresky C.A., and Fournier A. Pulmonary clearance of circulating endothelin-1 in dogs in vivo: Exclusive role of ETB receptors. J Appl Physiol 81 (1996) 1510-1515
60. Dymshitz J., and Vasko M.R. Endothelin-1 enhances capsaicin-induced peptide release and cGMP accumulation in cultures of rat sensory neurons. Neurosci Lett 167 (1994) 128-132
61. Ehrenreich H., Anderson R.W., Ogino Y., Rieckmann P., Costa T., Wood G.P., Coligan J.E., Kehrl J.H., and Fauci A.S. Selective autoregulation of endothelins in primary astrocyte cultures: Endothelin receptor-mediated potentiation of endothelin-1 secretion. New Biol 3 (1991) 135-141
62. Ehrenreich H., Burd P.R., Rottem M., Hultner L., Hylton J.B., Garfield M., Coligan J.E., Metcalfe D.D., and Fauci A.S. Endothelins belong to the assortment of mast cell-derived and mast cell-bound cytokines. New Biol 4 (1992) 147-156
63. Ehrenreich H., Costa T., Clouse K.A., Pluta R.M., Ogino Y., Coligan J.E., and Burd P.R. Thrombin is a regulator of astrocytic endothelin-1. Brain Res 600 (1993) 201-207
64. Elshourbagy N.A., Lee J.A., Korman D.R., Nuthalaganti P., Sylvester D.R., Dilella A.G., Sutiphong J.A., and Kumar C.S. Molecular cloning and characterization of the major endothelin receptor subtype in porcine cerebellum. Mol Pharmacol 41 (1992) 465-473
65. Elshourbagy N.A., Adamou J.E., Gagnon A.W., Wu H.L., Pullen M., and Nambi P. Molecular characterization of a novel human endothelin receptor splice variant. J Biol Chem 271 (1996) 25300-25307
66. England S., Bevan S., and Docherty R.J. PGE2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade. J Physiol 495 Pt 2 (1996) 429-440
67. Fang M., Kovacs K.J., Fisher L.L., and Larson A.A. Thrombin inhibits NMDA-mediated nociceptive activity in the mouse: possible mediation by endothelin. J Physiol 549 (2003) 903-917
68. Fareed M.U., Hans G., Atanda A., Strichartz G., and Davar G. Pharmacological characterization of acute pain behavior produced by application of endothelin-1 to rat sciatic nerve. J Pain 1 (2000) 46-53
69. Fehniger T.A., and Caligiuri M.A. Interleukin 15: Biology and relevance to human disease. Blood 97 (2001) 14-32
70. Ferreira S.H., Romitelli M., and de Nucci G. Endothelin-1 participation in overt and inflammatory pain. J Cardiovasc Pharmacol 13 Suppl 5 (1989) S220-S222
71. Fink E., and Oaklander A.L. Small-fiber neuropathy: answering the burning questions. Sci Aging Knowledge Environ (2006) pe7, 2006
72. Franco-Cereceda A., Rydh M., Lou Y.P., Dalsgaard C.J., and Lundberg J.M. Endothelin as a putative sensory neuropeptide in the guinea-pig: Different properties in comparison with calcitonin gene-related peptide. Regul Pept 32 (1991) 253-265
73. Freedman N.J., Ament A.S., Oppermann M., Stoffel R.H., Exum S.T., and Lefkowitz R.J. Phosphorylation and desensitization of human endothelin A and B receptors: Evidence for G protein-coupled receptor kinase specificity. J Biol Chem 272 (1997) 17734-17743
74. Fujita M., Andoh T., Saiki I., and Kuraishi Y. Involvement of endothelin and ET(A) endothelin receptor in mechanical allodynia in mice given orthotopic melanoma inoculation. J Pharmacol Sci 106 (2008) 257-263
75. Fukuroda T., Fujikawa T., Ozaki S., Ishikawa K., Yano M., and Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 199 (1994) 1461-1465
76. Gekel I., and Neher E. Application of an Epac activator enhances neurotransmitter release at excitatory central synapses. J Neurosci 28 (2008) 7991-8002
77. Giaid A., Gibson S.J., Ibrahim B.N., Legon S., Bloom S.R., Yanagisawa M., Masaki T., Varndell I.M., and Polak J.M. Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc Natl Acad Sci U S A 86 (1989) 7634-7638
78. Gingrich M.B., Junge C.E., Lyuboslavsky P., and Traynelis S.F. Potentiation of NMDA receptor function by the serine protease thrombin. J Neurosci 20 (2000) 4582-4595
79. Goblirsch M.J., Zwolak P.P., and Clohisy D.R. Biology of bone cancer pain. Clin Cancer Res 12 (2006) 6231s-6235s
80. Gokin A., and Strichartz G. Differential activity-dependence and TTX-sensitivity of pharmacologically characterized rat sciatic c-fibers recorded in vivo. Soc Neurosci Ann Mtg Abstracts 928 (2000) 13
81. Gokin A.P., Fareed M.U., Pan H.L., Hans G., Strichartz G.R., and Davar G. Local injection of endothelin-1 produces pain-like behavior and excitation of nociceptors in rats. J Neurosci 21 (2001) 5358-5366
82. Gold M.S., Levine J.D., and Correa A.M. Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro. J Neurosci 18 (1998) 10345-10355
83. Graido-Gonzalez E., Doherty J.C., Bergreen E.W., Organ G., Telfer M., and McMillen M.A. Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis. Blood 92 (1998) 2551-2555
84. Gregan B., Jurgensen J., Papsdorf G., Furkert J., Schaefer M., Beyermann M., Rosenthal W., and Oksche A. Ligand-dependent differences in the internalization of endothelin A and endothelin B receptor heterodimers. J Biol Chem 279 (2004) 27679-27687
85. Grimshaw M.J. Endothelins and hypoxia-inducible factor in cancer. Endocr Relat Cancer 14 (2007) 233-244
86. Griswold D.E., Douglas S.A., Martin L.D., Davis T.G., Davis L., Ao Z., Luttmann M.A., Pullen M., Nambi P., Hay D.W., and Ohlstein E.H. Endothelin B receptor modulates inflammatory pain and cutaneous inflammation. Mol Pharmacol 56 (1999) 807-812
87. Guise T.A., Yin J.J., and Mohammad K.S. Role of endothelin-1 in osteoblastic bone metastases. Cancer 97 (2003) 779-784
88. Guise T.A., Mohammad K.S., Clines G., Stebbins E.G., Wong D.H., Higgins L.S., Vessella R., Corey E., Padalecki S., Suva L., and Chirgwin J.M. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin Cancer Res 12 (2006) 6213s-6216s
89. Hammerman S.I., Kourembanas S., Conca T.J., Tucci M., Brauer M., and Farber H.W. Endothelin-1 production during the acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med 156 (1997) 280-285
90. Han S.P., Chen X.L., Westfall T.C., and Knuepfer M.M. Characterization of the depressor effect of intrathecal endothelin in anesthetized rats. Am J Physiol 260 (1991) H1685-H1691
91. Hans G., Deseure K., Robert D., and De Hert S. Neurosensory changes in a human model of endothelin-1 induced pain: A behavioral study. Neurosci Lett 418 (2007) 117-121
92. Harada N., Himeno A., Shigematsu K., Sumikawa K., and Niwa M. Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: Possible formation of an ETA-ETB receptor heterodimer. Cell Mol Neurobiol 22 (2002) 207-226
93. Hasselblatt M., Kamrowski-Kruck H., Jensen N., Schilling L., Kratzin H., Siren A.L., and Ehrenreich H. ETA and ETB receptor antagonists synergistically increase extracellular endothelin-1 levels in primary rat astrocyte cultures. Brain Res 785 (1998) 253-261
94. Hasselblatt M., Lewczuk P., Loffler B.M., Kamrowski-Kruck H., von Ahsen N., Siren A.L., and Ehrenreich H. Role of the astrocytic ET(B) receptor in the regulation of extracellular endothelin-1 during hypoxia. Glia 34 (2001) 18-26
95. Hasue F., Kuwaki T., Kisanuki Y.Y., Yanagisawa M., Moriya H., Fukuda Y., and Shimoyama M. Increased sensitivity to acute and persistent pain in neuron-specific endothelin-1 knockout mice. Neuroscience 130 (2005) 349-358
96. Hatae N., Aksentijevich N., Zemkova H.W., Kretschmannova K., Tomic M., and Stojilkovic S.S. Cloning and functional identification of novel endothelin receptor type A isoforms in pituitary. Mol Endocrinol 21 (2007) 1192-1204
97. He S., Dibas A., Yorio T., and Prasanna G. Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells. Exp Biol Med (Maywood) 232 (2007) 370-384
98. Held B., Pocock J.M., and Pearson H.A. Endothelin-1 inhibits voltage-sensitive Ca2+ channels in cultured rat cerebellar granule neurones via the ET-A receptor. Pflugers Arch 436 (1998) 766-775
99. Henry P.J. Endothelin-1 (ET-1)-induced contraction in rat isolated trachea: Involvement of ETA and ETB receptors and multiple signal transduction systems. Br J Pharmacol 110 (1993) 435-441
100. Herrmann E., Bogemann M., Bierer S., Eltze E., Toma M.I., Kopke T., Hertle L., and Wulfing C. The role of the endothelin axis and microvessel density in bladder cancer: Correlation with tumor angiogenesis and clinical prognosis. Oncol Rep 18 (2007) 133-138
101. Hirata Y., Emori T., Eguchi S., Kanno K., Imai T., Ohta K., and Marumo F. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 91 (1993) 1367-1373
102. Homolya L., Steinberg T.H., and Boucher R.C. Cell to cell communication in response to mechanical stress via bilateral release of ATP and UTP in polarized epithelia. J Cell Biol 150 (2000) 1349-1360
103. Honore J.C., Robert B., Vacher-Lavenu M.C., Chapron C., Breuiller-Fouche M., and Ferre F. Expression of endothelin receptors in human myometrium during pregnancy and in uterine leiomyomas. J Cardiovasc Pharmacol 36 (2000) S386-S389
104. Honore P., Rogers S.D., Schwei M.J., Salak-Johnson J.L., Luger N.M., Sabino M.C., Clohisy D.R., and Mantyh P.W. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 98 (2000) 585-598
105. Hori S., Komatsu Y., Shigemoto R., Mizuno N., and Nakanishi S. Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinology 130 (1992) 1885-1895
106. Horstmeyer A., Cramer H., Sauer T., Muller-Esterl W., and Schroeder C. Palmitoylation of endothelin receptor A: Differential modulation of signal transduction activity by post-translational modification. J Biol Chem 271 (1996) 20811-20819
107. Houck C.S., Khodorova A., Reale A.M., Strichartz G.R., and Davar G. Sensory fibers resistant to the actions of tetrodotoxin mediate nocifensive responses to local administration of endothelin-1 in rats. Pain 110 (2004) 719-726
108. Hounsom L., and Tomlinson D.R. Does neuropathy develop in animal models?. Clin Neurosci 4 (1997) 380-389
109. Hunter A.R., and Turner A.J. Expression and localization of endothelin-converting enzyme-1 isoforms in human endothelial cells. Exp Biol Med (Maywood) 231 (2006) 718-722
110. Imokawa G., Yada Y., and Miyagishi M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem 267 (1992) 24675-24680
111. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., and Masaki T. The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A 86 (1989) 2863-2867
112. Ishibashi M., Saito K., Watanobe K., Uesugi S., Furue H., and Yamaji T. Plasma endothelin-1 levels in patients with disseminated intravascular coagulation. N Engl J Med 324 (1991) 1516-1517
113. Jacob E., Beyer J.E., Miaskowski C., Savedra M., Treadwell M., and Styles L. Are there phases to the vaso-occlusive painful episode in sickle cell disease?. J Pain Symptom Manage 29 (2005) 392-400
114. Jacques D., Descorbeth M., Abdel-Samad D., Provost C., Perreault C., and Jules F. The distribution and density of ET-1 and its receptors are different in human right and left ventricular endocardial endothelial cells. Peptides 26 (2005) 1427-1435
115. Janig W., Levine J.D., and Michaelis M. Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma. Prog Brain Res 113 (1996) 161-184
116. Jarvis M.F., Wessale J.L., Zhu C.Z., Lynch J.J., Dayton B.D., Calzadilla S.V., Padley R.J., Opgenorth T.J., and Kowaluk E.A. ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain. Eur J Pharmacol 388 (2000) 29-35
117. Ji R.R., and Strichartz G. Cell signaling and the genesis of neuropathic pain. Sci STKE (2004) reE14, 2004
118. Jiang Z.Y., Zhou Q.L., Chatterjee A., Feener E.P., Myers Jr. M.G., White M.F., and King G.L. Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes 48 (1999) 1120-1130
119. Johnstrom P., Fryer T.D., Richards H.K., Harris N.G., Barret O., Clark J.C., Pickard J.D., and Davenport A.P. Positron emission tomography using 18F-labelled endothelin-1 reveals prevention of binding to cardiac receptors owing to tissue-specific clearance by ET B receptors in vivo. Br J Pharmacol 144 (2005) 115-122
120. Joosten L.A., Lubberts E., Helsen M.M., and van den Berg W.B. Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J Immunol 159 (1997) 4094-4102
121. Kadono S., Manaka I., Kawashima M., Kobayashi T., and Imokawa G. The role of the epidermal endothelin cascade in the hyperpigmentation mechanism of lentigo senilis. J Invest Dermatol 116 (2001) 571-577
122. Kamei J., Hitosugi H., Kawashima N., Misawa M., and Kasuya Y. Antinociceptive effects of intrathecally administered endothelin-1 in mice. Neurosci Lett 153 (1993) 69-72
123. Kamisawa T., and Satake K. Clinical management of autoimmune pancreatitis. Adv Med Sci 52 (2007) 61-65
124. Kar S., Chabot J.G., and Quirion R. Quantitative autoradiographic localisation of [125I]endothelin-1 binding sites in spinal cord and dorsal root ganglia of the rat. Neurosci Lett 133 (1991) 117-120
125. Kasuya Y., Abe Y., Hama H., Sakurai T., Asada S., Masaki T., and Goto K. Endothelin-1 activates mitogen-activated protein kinases through two independent signalling pathways in rat astrocytes. Biochem Biophys Res Commun 204 (1994) 1325-1333
126. Katugampola R., Church M.K., and Clough G.F. The neurogenic vasodilator response to endothelin-1: A study in human skin in vivo. Exp Physiol 85 (2000) 839-846
127. Kefford R., Beith J.M., Van Hazel G.A., Millward M., Trotter J.M., Wyld D.K., Kusic R., Shreeniwas R., Morganti A., Ballmer A., Segal E., Nayler O., and Clozel M. A phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma. Invest New Drugs 25 (2007) 247-252
128. Khodorova A., Fareed M.U., Gokin A., Strichartz G.R., and Davar G. Local injection of a selective endothelin-B receptor agonist inhibits endothelin-1-induced pain-like behavior and excitation of nociceptors in a naloxone-sensitive manner. J Neurosci 22 (2002) 7788-7796
129. Khodorova A., Navarro B., Jouaville L.S., Murphy J.E., Rice F.L., Mazurkiewicz J.E., Long-Woodward D., Stoffel M., Strichartz G.R., Yukhananov R., and Davar G. Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury. Nat Med 9 (2003) 1055-1061
130. Khodorova A., Vasko M.R., Ritcher J.A., and Strichartz G. NMDA receptors favor tactile allodynia induced by injection of low concentrations of endothelin-1 into the rat's hind paw. Soc Neurosci Ann Mtg Abstracts 245 (2006) 23
131. Kidd B.L., and Urban L.A. Mechanisms of inflammatory pain. Br J Anaesth 87 (2001) 3-11
132. Klass M., Hord A., Wilcox M., Denson D., and Csete M. A role for endothelin in neuropathic pain after chronic constriction injury of the sciatic nerve. Anesth Analg 101 (2005) 1757-1762
133. Koizumi S., Kataoka Y., Niwa M., Yamashita K., Taniyama K., and Kudo Y. Endothelin increased [Ca2+]i in cultured neurones and slices of rat hippocampus. Neuroreport 5 (1994) 1077-1080
134. Korn J.H., Mayes M., Matucci Cerinic M., Rainisio M., Pope J., Hachulla E., Rich E., Carpentier P., Molitor J., Seibold J.R., Hsu V., Guillevin L., Chatterjee S., Peter H.H., Coppock J., Herrick A., Merkel P.A., Simms R., Denton C.P., Furst D., Nguyen N., Gaitonde M., and Black C. Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 50 (2004) 3985-3993
135. Koyama Y., Mizobata T., Yamamoto N., Hashimoto H., Matsuda T., and Baba A. Endothelins stimulate expression of cyclooxygenase 2 in rat cultured astrocytes. J Neurochem 73 (1999) 1004-1011
136. Krystek Jr. S.R., Patel P.S., Rose P.M., Fisher S.M., Kienzle B.K., Lach D.A., Liu E.C., Lynch J.S., Novotny J., and Webb M.L. Mutation of peptide binding site in transmembrane region of a G protein-coupled receptor accounts for endothelin receptor subtype selectivity. J Biol Chem 269 (1994) 12383-12386
137. Kvien T.K. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 22 (2004) 1-12
138. Lahav R., Suva M.L., Rimoldi D., Patterson P.H., and Stamenkovic I. Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanomas. Cancer Res 64 (2004) 8945-8953
139. Lalich M., McNeel D.G., Wilding G., and Liu G. Endothelin receptor antagonists in cancer therapy. Cancer Invest 25 (2007) 785-794
140. Li J., Xiang B., Su W., Zhang X., Huang Y., and Ma L. Agonist-induced formation of opioid receptor-G protein-coupled receptor kinase (GRK)-G beta gamma complex on membrane is required for GRK2 function in vivo. J Biol Chem 278 (2003) 30219-30226
141. Liew F.Y., and McInnes I.B. The role of innate mediators in inflammatory response. Mol Immunol 38 (2002) 887-890
142. Lin L.F., Huang P.T., Ho K.S., and Tung J.N. Autoimmune chronic pancreatitis. J Chin Med Assoc 71 (2008) 14-22
143. Luscher T.F., and Barton M. Endothelins and endothelin receptor antagonists: Therapeutic considerations for a novel class of cardiovascular drugs. Circulation 102 (2000) 2434-2440
144. MacCumber M.W., Ross C.A., and Snyder S.H. Endothelin in brain: Receptors, mitogenesis, and biosynthesis in glial cells. Proc Natl Acad Sci U S A 87 (1990) 2359-2363
145. Manadan A.M., Sequeira W., and Block J.A. The treatment of psoriatic arthritis. Am J Ther 13 (2006) 72-79
146. Mantyh P.W. A mechanism based understanding of cancer pain. Pain 96 (2002) 1-2
147. Mantyh P.W., Clohisy D.R., Koltzenburg M., and Hunt S.P. Molecular mechanisms of cancer pain. Nat Rev Cancer 2 (2002) 201-209
148. Masaki T. Endothelins: Homeostatic and compensatory actions in the circulatory and endocrine systems. Endocr Rev 14 (1993) 256-268
149. Masaki T. Historical review: Endothelin. Trends Pharmacol Sci 25 (2004) 219-224
150. Matwyshyn G.A., Bhalla S., and Gulati A. Endothelin ETA receptor blockade potentiates morphine analgesia but does not affect gastrointestinal transit in mice. Eur J Pharmacol 543 (2006) 48-53
151. Maves T.J., Pechman P.S., Gebhart G.F., and Meller S.T. Possible chemical contribution from chromic gut sutures produces disorders of pain sensation like those seen in man. Pain 54 (1993) 57-69
152. Maxwell M.J., Goldie R.G., and Henry P.J. Ca2+ signalling by endothelin receptors in rat and human cultured airway smooth muscle cells. Br J Pharmacol 125 (1998) 1768-1778
153. McKelvy A.D., Mark T.R., and Sweitzer S.M. Age- and sex-specific nociceptive response to endothelin-1. J Pain 8 (2007) 657-666
154. McKelvy A.D., and Sweitzer S.M. Endothelin-1 exposure in infancy, but not in young childhood sensitizes males and de-sensitizes females to endothelin-1 induced pain later in development. Soc Neurosci Ann Mtg Abstracts 72 (2007) 6
155. Medhurst S.J., Walker K., Bowes M., Kidd B.L., Glatt M., Muller M., Hattenberger M., Vaxelaire J., O'Reilly T., Wotherspoon G., Winter J., Green J., and Urban L. A rat model of bone cancer pain. Pain 96 (2002) 129-140
156. Menendez L., Lastra A., Hidalgo A., and Baamonde A. Nociceptive reaction and thermal hyperalgesia induced by local ET-1 in mice: A behavioral and Fos study. Naunyn Schmiedebergs Arch Pharmacol 367 (2003) 28-34
157. Mirshahi T., Mittal V., Zhang H., Linder M.E., and Logothetis D.E. Distinct sites on G protein beta gamma subunits regulate different effector functions. J Biol Chem 277 (2002) 36345-36350
158. Miyamoto Y., Yoshimasa T., Arai H., Takaya K., Ogawa Y., Itoh H., and Nakao K. Alternative RNA splicing of the human endothelin-A receptor generates multiple transcripts. Biochem J 313 Pt 3 (1996) 795-801
159. Miyasaka N., Hirata Y., Ando K., Sato K., Morita H., Shichiri M., Kanno K., Tomita K., and Marumo F. Increased production of endothelin-1 in patients with inflammatory arthritides. Arthritis Rheum 35 (1992) 397-400
160. Mizuguchi T., Nishiyama M., Moroi K., Tanaka H., Saito T., Masuda Y., Masaki T., de Wit D., Yanagisawa M., and Kimura S. Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouse. Br J Pharmacol 120 (1997) 1427-1430
161. Motrich R.D., Maccioni M., Riera C.M., and Rivero V.E. Autoimmune prostatitis: State of the art. Scand J Immunol 66 (2007) 217-227
162. Motta E.M., Calixto J.B., and Rae G.A. Mechanical hyperalgesia induced by endothelin-1 in rats is mediated via phospholipase C, protein kinase C, and MAP kinases. Exp Biol Med (Maywood) 231 (2006) 1141-1145
163. Mujenda F.H., Duarte A.M., Reilly E.K., and Strichartz G.R. Cutaneous endothelin-A receptors elevate post-incisional pain. Pain 133 (2007) 161-173
164. Muslu A., Islek I., Gok F., Aliyazicioglu Y., Dagdemir A., Dundaroz R., Kucukoduk S., and Sakarcan A. Endothelin levels in Henoch-Schonlein purpura. Pediatr Nephrol 17 (2002) 920-925
165. Nambi P., Wu H.L., Ye D., Gagnon A., and Elshourbagy N. Characterization of a novel porcine endothelin(B) receptor splice variant. J Pharmacol Exp Ther 292 (2000) 247-253
166. Nelson J., Bagnato A., Battistini B., and Nisen P. The endothelin axis: Emerging role in cancer. Nat Rev Cancer 3 (2003) 110-116
167. Nelson J.B., Chan-Tack K., Hedican S.P., Magnuson S.R., Opgenorth T.J., Bova G.S., and Simons J.W. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res 56 (1996) 663-668
168. Nikolov R., Maslarova J., Semkova I., and Moyanova S. Intracerebroventricular endothelin-1 (ET-1) produces Ca(2+)-mediated antinociception in mice. Methods Find Exp Clin Pharmacol 14 (1992) 229-233
169. Nishimura T., Akasu T., and Krier J. Endothelin modulates calcium channel current in neurones of rabbit pelvic parasympathetic ganglia. Br J Pharmacol 103 (1991) 1242-1250
170. Noguchi K., Kowalski K., Traub R., Solodkin A., Iadarola M.J., and Ruda M.A. Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are colocalized in spinal cord neurons. Brain Res Mol Brain Res 10 (1991) 227-233
171. Obara K., Koide M., Ishikawa T., Tanabe Y., and Nakayama K. Protein kinase C delta but not PKC epsilon activity is involved in contractile potentiation by endothelin-1 in the porcine coronary artery. J Cardiovasc Pharmacol 36 (2000) S120-S121
172. Oksche A., Boese G., Horstmeyer A., Furkert J., Beyermann M., Bienert M., and Rosenthal W. Late endosomal/lysosomal targeting and lack of recycling of the ligand-occupied endothelin B receptor. Mol Pharmacol 57 (2000) 1104-1113
173. Opgenorth T.J., Wessale J.L., Dixon D.B., Adler A.L., Calzadilla S.V., Padley R.J., and Wu-Wong J.R. Effects of endothelin receptor antagonists on the plasma immunoreactive endothelin-1 level. J Cardiovasc Pharmacol 36 (2000) S292-S296
174. Orry A.J., and Wallace B.A. Modeling and docking the endothelin G-protein-coupled receptor. Biophys J 79 (2000) 3083-3094
175. Osawa Y., Koizumi H., Fukaya T., Yasui C., Ohkawara A., and Ueda T. Adenylate cyclase induces intracellular Ca2+ increase in single human epidermal keratinocytes of the epidermal sheet as measured by digital imaging microscopy using Fura 2-AM. Arch Dermatol Res 283 (1991) 91-95
176. Ozaki S., Ohwaki K., Ihara M., Ishikawa K., and Yano M. Coexpression studies with endothelin receptor subtypes indicate the existence of intracellular cross-talk between ET(A) and ET(B) receptors. J Biochem 121 (1997) 440-447
177. Paasche J.D., Attramadal T., Sandberg C., Johansen H.K., and Attramadal H. Mechanisms of endothelin receptor subtype-specific targeting to distinct intracellular trafficking pathways. J Biol Chem 276 (2001) 34041-34050
178. Paasche J.D., Attramadal T., Kristiansen K., Oksvold M.P., Johansen H.K., Huitfeldt H.S., Dahl S.G., and Attramadal H. Subtype-specific sorting of the ETA endothelin receptor by a novel endocytic recycling signal for G protein-coupled receptors. Mol Pharmacol 67 (2005) 1581-1590
179. Papandreou C.N., Usmani B., Geng Y., Bogenrieder T., Freeman R., Wilk S., Finstad C.L., Reuter V.E., Powell C.T., Scheinberg D., Magill C., Scher H.I., Albino A.P., and Nanus D.M. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat Med 4 (1998) 50-57
180. Peduto Eberl L., Bovey R., and Juillerat-Jeanneret L. Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cells. Br J Cancer 88 (2003) 788-795
181. Peters C.M., Lindsay T.H., Pomonis J.D., Luger N.M., Ghilardi J.R., Sevcik M.A., and Mantyh P.W. Endothelin and the tumorigenic component of bone cancer pain. Neuroscience 126 (2004) 1043-1052
182. Pflug B.R., Zheng H., Udan M.S., D'Antonio J.M., Marshall F.F., Brooks J.D., and Nelson J.B. Endothelin-1 promotes cell survival in renal cell carcinoma through the ET(A) receptor. Cancer Lett 246 (2007) 139-148
183. Pickering V., Jay Gupta R., Quang P., Jordan R.C., and Schmidt B.L. Effect of peripheral endothelin-1 concentration on carcinoma-induced pain in mice. Eur J Pain 12 (2008) 293-300
184. Piovezan A.P., D'Orleans-Juste P., Tonussi C.R., and Rae G.A. Endothelins potentiate formalin-induced nociception and paw edema in mice. Can J Physiol Pharmacol 75 (1997) 596-600
185. Piovezan A.P., D'Orleans-Juste P., Tonussi C.R., and Rae G.A. Effects of endothelin-1 on capsaicin-induced nociception in mice. Eur J Pharmacol 351 (1998) 15-22
186. Piovezan A.P., D'Orleans-Juste P., Souza G.E., and Rae G.A. Endothelin-1-induced ET(A) receptor-mediated nociception, hyperalgesia and oedema in the mouse hind-paw: Modulation by simultaneous ET(B) receptor activation. Br J Pharmacol 129 (2000) 961-968
187. Piovezan A.P., D'Orleans-Juste P., Frighetto M., Souza G.E., Henriques M.G., and Rae G.A. Endothelins contribute towards nociception induced by antigen in ovalbumin-sensitised mice. Br J Pharmacol 141 (2004) 755-763
188. Plant T.D., Zollner C., Kepura F., Mousa S.S., Eichhorst J., Schaefer M., Furkert J., Stein C., and Oksche A. Endothelin potentiates TRPV1 via ETA receptor-mediated activation of protein kinase C. Mol Pain 3 (2007) 35
189. Plater-Zyberk C., Joosten L.A., Helsen M.M., Sattonnet-Roche P., Siegfried C., Alouani S., van De Loo F.A., Graber P., Aloni S., Cirillo R., Lubberts E., Dinarello C.A., van Den Berg W.B., and Chvatchko Y. Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J Clin Invest 108 (2001) 1825-1832
190. Pogatzki-Zahn E.M., Shimizu I., Caterina M., and Raja S.N. Heat hyperalgesia after incision requires TRPV1 and is distinct from pure inflammatory pain. Pain 115 (2005) 296-307
191. Polikepahad S., Moore R.M., and Venugopal C.S. Endothelins and airways: A short review. Res Commun Mol Pathol Pharmacol 119 (2006) 3-51
192. Pomonis J.D., Rogers S.D., Peters C.M., Ghilardi J.R., and Mantyh P.W. Expression and localization of endothelin receptors: Implications for the involvement of peripheral glia in nociception. J Neurosci 21 (2001) 999-1006
193. Pope J.E. The diagnosis and treatment of Raynaud's phenomenon: A practical approach. Drugs 67 (2007) 517-525
194. Rae G.A., and Henriques M.G. Endothelins in inflammation. In: Said S. (Ed). Pro-inflammatory and Anti-inflammatory Peptides (1998), Marcel Dekker, New York 163-202
195. Raffa R.B., Schupsky J.J., Martinez R.P., and Jacoby H.I. Endothelin-1-induced nociception. Life Sci 49 (1991) PL61-PL65
196. Raffa R.B., Schupsky J.J., and Jacoby H.I. Endothelin-induced nociception in mice: Mediation by ETA and ETB receptors. J Pharmacol Exp Ther 276 (1996) 647-651
197. Raffa R.B., Schupsky J.J., Lee D.K., and Jacoby H.I. Characterization of endothelin-induced nociception in mice: Evidence for a mechanistically distinct analgesic model. J Pharmacol Exp Ther 278 (1996) 1-7
198. Raghavendra V., Tanga F.Y., and DeLeo J.A. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci 20 (2004) 467-473
199. Rendell M.S., Finnegan M.F., Healy J.C., Lind A., Milliken B.K., Finney D.E., and Bonner R.F. The relationship of laser-Doppler skin blood flow measurements to the cutaneous microvascular anatomy. Microvasc Res 55 (1998) 3-13
200. Rendell M.S., Johnson M.L., Smith D., Finney D., Capp C., Lammers R., and Lancaster S. Skin blood flow response in the rat model of wound healing: Expression of vasoactive factors. J Surg Res 107 (2002) 18-26
201. Rosano L., Spinella F., Di Castro V., Nicotra M.R., Albini A., Natali P.G., and Bagnato A. Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo. Am J Pathol 163 (2003) 753-762
202. Rosano L., Di Castro V., Spinella F., Tortora G., Nicotra M.R., Natali P.G., and Bagnato A. Combined targeting of endothelin A receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity. Cancer Res 67 (2007) 6351-6359
203. Rose P.M., Krystek Jr. S.R., Patel P.S., Liu E.C., Lynch J.S., Lach D.A., Fisher S.M., and Webb M.L. Aspartate mutation distinguishes ETA but not ETB receptor subtype-selective ligand binding while abolishing phospholipase C activation in both receptors. FEBS Lett 361 (1995) 243-249
204. Rubanyi G.M., and Polokoff M.A. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46 (1994) 325-415
205. Ruchatz H., Leung B.P., Wei X.Q., McInnes I.B., and Liew F.Y. Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: A role for IL-15 in development of antigen-induced immunopathology. J Immunol 160 (1998) 5654-5660
206. Sabino M.A., Ghilardi J.R., Jongen J.L., Keyser C.P., Luger N.M., Mach D.B., Peters C.M., Rogers S.D., Schwei M.J., de Felipe C., and Mantyh P.W. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. Cancer Res 62 (2002) 7343-7349
207. Sachs D., Cunha F.Q., and Ferreira S.H. Peripheral analgesic blockade of hypernociception: Activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway. Proc Natl Acad Sci U S A 101 (2004) 3680-3685
208. Saida K., Mitsui Y., and Ishida N. A novel peptide, vasoactive intestinal contractor, of a new (endothelin) peptide family: Molecular cloning, expression, and biological activity. J Biol Chem 264 (1989) 14613-14616
209. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., and Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348 (1990) 732-735
210. Sakurai T., Yanagisawa M., and Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci 13 (1992) 103-108
211. Sawynok J., Esser M.J., and Reid A.R. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain 82 (1999) 149-158
212. Schaible H.G., Ebersberger A., and Von Banchet G.S. Mechanisms of pain in arthritis. Ann N Y Acad Sci 966 (2002) 343-354
213. Schmidt B.L., Pickering V., Liu S., Quang P., Dolan J., Connelly S.T., and Jordan R.C. Peripheral endothelin A receptor antagonism attenuates carcinoma-induced pain. Eur J Pain 11 (2007) 406-414
214. Schwartz R.A., and Nervi S.J. Erythema nodosum: A sign of systemic disease. Am Fam Physician 75 (2007) 695-700
215. Selenko-Gebauer N., Duschek N., Minimair G., Stingl G., and Karlhofer F. Successful treatment of patients with severe secondary Raynaud's phenomenon with the endothelin receptor antagonist bosentan. Rheumatology (Oxford) 45 Suppl 3 (2006) iii45-iii48
216. Seong J., Park H.C., Kim J., Kim U.J., and Lee B.W. Radiation-induced alteration of pain-related signals in an animal model with bone invasion from cancer. Ann N Y Acad Sci 1030 (2004) 179-186
217. Sessa W.C., and Nasjletti A. Dexamethasone selectively attenuates prostanoid-induced vasoconstrictor responses in vitro. Circ Res 66 (1990) 383-388
218. Shi-Wen X., Chen Y., Denton C.P., Eastwood M., Renzoni E.A., Bou-Gharios G., Pearson J.D., Dashwood M., du Bois R.M., Black C.M., Leask A., and Abraham D.J. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell 15 (2004) 2707-2719
219. Shraga-Levine Z., Galron R., and Sokolovsky M. Cyclic GMP formation in rat cerebellar slices is stimulated by endothelins via nitric oxide formation and by sarafotoxins via formation of carbon monoxide. Biochemistry 33 (1994) 14656-14659
220. Shraga-Levine Z., and Sokolovsky M. cGMP formation in rat atrial slices is ligand and endothelin receptor subtype specific. Circ Res 78 (1996) 424-430
221. Shraga-Levine Z., and Sokolovsky M. Functional coupling of G proteins to endothelin receptors is ligand and receptor subtype specific. Cell Mol Neurobiol 20 (2000) 305-317
222. Shyamala V., Moulthrop T.H., Stratton-Thomas J., and Tekamp-Olson P. Two distinct human endothelin B receptors generated by alternative splicing from a single gene. Cell Mol Biol Res 40 (1994) 285-296
223. Smollich M., and Wulfing P. The endothelin axis: A novel target for pharmacotherapy of female malignancies. Curr Vasc Pharmacol 5 (2007) 239-248
224. Sokolovsky M. Endothelins and sarafotoxins: Physiological regulation, receptor subtypes and transmembrane signaling. Pharmacol Ther 54 (1992) 129-149
225. Sokolovsky M. Endothelins and sarafotoxins: Receptor heterogeneity. Int J Biochem 26 (1994) 335-340
226. Sokolovsky M., Shraga-Levine Z., and Galron R. Ligand-specific stimulation/inhibition of cAMP formation by a novel endothelin receptor subtype. Biochemistry 33 (1994) 11417-11419
227. Southall M.D., Li T., Gharibova L.S., Pei Y., Nicol G.D., and Travers J.B. Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther 304 (2003) 217-222
228. Steen K.H., Steen A.E., and Reeh P.W. A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro. J Neurosci 15 (1995) 3982-3989
229. Steinhoff M., Stander S., Seeliger S., Ansel J.C., Schmelz M., and Luger T. Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol 139 (2003) 1479-1488
230. Strengell M., Matikainen S., Siren J., Lehtonen A., Foster D., Julkunen I., and Sareneva T. IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J Immunol 170 (2003) 5464-5469
231. Sugden P.H. An overview of endothelin signaling in the cardiac myocyte. J Mol Cell Cardiol 35 (2003) 871-886
232. Sullivan J.C., Goodchild T.T., Cai Z., Pollock D.M., and Pollock J.S. Endothelin(A) (ET(A)) and ET(B) receptor-mediated regulation of nitric oxide synthase 1 (NOS1) and NOS3 isoforms in the renal inner medulla. Acta Physiol (Oxf) 191 (2007) 329-336
233. Suzuki T. Endothelin-1-induced depolarization and hyperpolarization in submandibular ganglion neurons. Bull Tokyo Dent Coll 45 (2004) 189-192
234. Szolcsanyi J., Oroszi G., Nemeth J., Szilvassy Z., Blasig I.E., and Tosaki A. Functional and biochemical evidence for capsaicin-induced neural endothelin release in isolated working rat heart. Eur J Pharmacol 419 (2001) 215-221
235. Takahashi H., Miyokawa N., Katagiri M., and Iizuka H. Expression of guanine nucleotide binding proteins, Gs and Gi, in mRNAs in epidermal keratinocytes. Arch Dermatol Res 282 (1990) 392-396
236. Takasuka T., Akiyama N., Horii I., Furuichi Y., and Watanabe T. Different stability of ligand-receptor complex formed with two endothelin receptor species, ETA and ETB. J Biochem 111 (1992) 748-753
237. Takigawa M., Sakurai T., Kasuya Y., Abe Y., Masaki T., and Goto K. Molecular identification of guanine-nucleotide-binding regulatory proteins which couple to endothelin receptors. Eur J Biochem 228 (1995) 102-108
238. Tan E.M., Sugiura K., and Gupta S. The case definition of chronic fatigue syndrome. J Clin Immunol 22 (2002) 8-12
239. Tang W., Tu Y., Nayak S.K., Woodson J., Jehl M., and Ross E.M. Gbetagamma inhibits G-alpha GTPase-activating proteins by inhibition of G-alpha-GTP binding during stimulation by receptor. J Biol Chem 281 (2006) 4746-4753
240. Tanga F.Y., Raghavendra V., and DeLeo J.A. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem Int 45 (2004) 397-407
241. Tessier S., Boivin S., Aubin J., Lampron P., Detheux M., and Fournier A. Transmembrane domain V of the endothelin-A receptor is a binding domain of ETA-selective TTA-386-derived photoprobes. Biochemistry 44 (2005) 7844-7854
242. Tirapelli C.R., Casolari D.A., Yogi A., Montezano A.C., Tostes R.C., Legros E., D'Orleans-Juste P., and de Oliveira A.M. Functional characterization and expression of endothelin receptors in rat carotid artery: Involvement of nitric oxide, a vasodilator prostanoid and the opening of K+ channels in ETB-induced relaxation. Br J Pharmacol 146 (2005) 903-912
243. Trentham D.E., Townes A.S., and Kang A.H. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 146 (1977) 857-868
244. Tsuboi R., Sato C., Shi C.M., Nakamura T., Sakurai T., and Ogawa H. Endothelin-1 acts as an autocrine growth factor for normal human keratinocytes. J Cell Physiol 159 (1994) 213-220
245. Tuck R.R., Schmelzer J.D., and Low P.A. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107 Pt 3 (1984) 935-950
246. Usmani B.A., Harden B., Maitland N.J., and Turner A.J. Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines. Clin Sci (Lond) 48 103 Suppl (2002) 314S-317S
247. Verri Jr. W.A., Cunha T.M., Parada C.A., Wei X.Q., Ferreira S.H., Liew F.Y., and Cunha F.Q. IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin. Proc Natl Acad Sci U S A 103 (2006) 9721-9725
248. Verri Jr. W.A., Cunha T.M., Parada C.A., Poole S., Liew F.Y., Ferreira S.H., and Cunha F.Q. Antigen-induced inflammatory mechanical hypernociception in mice is mediated by IL-18. Brain Behav Immun 21 (2007) 535-543
249. Verri Jr. W.A., Guerrero A.T., Fukada S.Y., Valerio D.A., Cunha T.M., Xu D., Ferreira S.H., Liew F.Y., and Cunha F.Q. IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc Natl Acad Sci U S A 105 (2008) 2723-2728
250. Vigne P., Ladoux A., and Frelin C. Endothelins activate Na+/H+ exchange in brain capillary endothelial cells via a high affinity endothelin-3 receptor that is not coupled to phospholipase C. J Biol Chem 266 (1991) 5925-5928
251. Vinik A.I. Advances in diabetes for the millennium: New treatments for diabetic neuropathies. Med Gen Med 6 (2004) 13
252. Voerman H.J., Stehouwer C.D., van Kamp G.J., Strack van Schijndel R.J., Groeneveld A.B., and Thijs L.G. Plasma endothelin levels are increased during septic shock. Crit Care Med 20 (1992) 1097-1101
253. Wacnik P.W., Eikmeier L.J., Ruggles T.R., Ramnaraine M.L., Walcheck B.K., Beitz A.J., and Wilcox G.L. Functional interactions between tumor and peripheral nerve: Morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J Neurosci 21 (2001) 9355-9366
254. Wieseler-Frank J., Maier S.F., and Watkins L.R. Immune-to-brain communication dynamically modulates pain: Physiological and pathological consequences. Brain Behav Immun 19 (2005) 104-111
255. Wiygul R.D. Prostatitis: Epidemiology of inflammation. Curr Urol Rep 6 (2005) 282-289
256. Woo Y.C., Park S.S., Subieta A.R., and Brennan T.J. Changes in tissue pH and temperature after incision indicate acidosis may contribute to postoperative pain. Anesthesiology 101 (2004) 468-475
257. Worda M., Sgonc R., Dietrich H., Niederegger H., Sundick R.S., Gershwin M.E., and Wick G. In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay. Arthritis Rheum 48 (2003) 2605-2614
258. Xu Q.G., Cheng C., Sun H., Thomsen K., and Zochodne D.W. Local sensory ganglion ischemia induced by endothelin vasoconstriction: Vulnerability of diabetic neurons and microvessels. Neuroscience 122 (2003) 897-905
259. Yamamoto H., Kawamata T., Ninomiya T., Omote K., and Namiki A. Endothelin-1 enhances capsaicin-evoked intracellular Ca2+ response via activation of endothelin a receptor in a protein kinase Cepsilon-dependent manner in dorsal root ganglion neurons. Neuroscience 137 (2006) 949-960
260. Yamamoto T., Shimoyama N., Asano H., and Mizuguchi T. Analysis of the role of endothelin-A and endothelin-B receptors on nociceptive information transmission in the spinal cord with FR139317, an endothelin-A receptor antagonist, and sarafotoxin S6c, an endothelin-B receptor agonist. J Pharmacol Exp Ther 271 (1994) 156-163
261. Yanagisawa M., Kurihara H., Kimura S., Goto K., and Masaki T. A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels. J Hypertens Suppl 6 (1988) S188-S191
262. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988) 411-415
263. Yin J.J., Mohammad K.S., Kakonen S.M., Harris S., Wu-Wong J.R., Wessale J.L., Padley R.J., Garrett I.R., Chirgwin J.M., and Guise T.A. A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases. Proc Natl Acad Sci U S A 100 (2003) 10954-10959
264. Yogi A., Callera G.E., Montezano A.C., Aranha A.B., Tostes R.C., Schiffrin E.L., and Touyz R.M. Endothelin-1, but not Ang II, activates MAP kinases through c-Src independent Ras-Raf dependent pathways in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 27 (2007) 1960-1967
265. Yohn J.J., Morelli J.G., Walchak S.J., Rundell K.B., Norris D.A., and Zamora M.R. Cultured human keratinocytes synthesize and secrete endothelin-1. J Invest Dermatol 100 (1993) 23-26
266. Yohn J.J., Smith C., Stevens T., Morelli J.G., Shurnas L.R., Walchak S.J., Hoffman T.A., Kelley K.K., Escobedo-Morse A., Yanagisawa M., Kane M.A., and Zamora M.R. Autoregulation of endothelin-1 secretion by cultured human keratinocytes via the endothelin B receptor. Biochim Biophys Acta 1224 (1994) 454-458
267. Yoshimoto S., Ishizaki Y., Kurihara H., Sasaki T., Yoshizumi M., Yanagisawa M., Yazaki Y., Masaki T., Takakura K., and Murota S. Cerebral microvessel endothelium is producing endothelin. Brain Res 508 (1990) 283-285
268. Yuyama H., Koakutsu A., Fujiyasu N., Tanahashi M., Fujimori A., Sato S., Shibasaki K., Tanaka S., Sudoh K., Sasamata M., and Miyata K. Effects of selective endothelin ET(A) receptor antagonists on endothelin-1-induced potentiation of cancer pain. Eur J Pharmacol 492 (2004) 177-182
269. Yuyama H., Sonoda R., Shibasaki K., Fujimori A., Sudoh K., Sasamata M., and Miyata K. Effect of single oral administration of YM598, a novel selective endothelin ETA receptor antagonist, on blood pressure in normotensive and hypertensive rats. Vascul Pharmacol 41 (2004) 27-34
270. Zhang Y.H., Vasko M.R., and Nicol G.D. Ceramide, a putative second messenger for nerve growth factor, modulates the TTX-resistant Na(+) current and delayed rectifier K(+) current in rat sensory neurons. J Physiol 544 (2002) 385-402
271. Zhao C., Wacnik P.W., Tall J.M., Johns D.C., Wilcox G.L., Meyer R.A., and Raja S.N. Analgesic effects of a soy-containing diet in three murine bone cancer pain models. J Pain 5 (2004) 104-110
272. Zhou Q.L., Strichartz G., and Davar G. Endothelin-1 activates ET(A) receptors to increase intracellular calcium in model sensory neurons. Neuroreport 12 (2001) 3853-3857
273. Zhou Z., Davar G., and Strichartz G. Endothelin-1 (ET-1) selectively enhances the activation gating of slowly inactivating tetrodotoxin-resistant sodium currents in rat sensory neurons: A mechanism for the pain-inducing actions of ET-1. J Neurosci 22 (2002) 6325-6330
274. Zochodne D.W., Ho L.T., and Gross P.M. Acute endoneurial ischemia induced by epineurial endothelin in the rat sciatic nerve. Am J Physiol 263 (1992) H1806-H1810
275. Zochodne D.W., and Cheng C. Diabetic peripheral nerves are susceptible to multifocal ischemic damage from endothelin. Brain Res 838 (1999) 11-17
276. Zou S., Ren K., Dubner R., Khodorova A., and Davar G. Endothelin receptor mechanisms of adjuvant-induced hyperalgesia in rats. Soc Neurosci Ann Mtg Abstracts 588 (2003) 16